Investors & Media

SEC Filing Details

Document Details

Form
Filing Date
Apr 22, 2020
Document Date
Apr 8, 2020
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Sangamo Therapeutics, Inc.
Issuer
SANGAMO THERAPEUTICS, INC
Filer
BIOGEN INC.